1
|
Yetek İ, Mert S, Tunca E, Bayrakdar A, Kasımoğulları R. Synthesis, molecular docking and molecular dynamics simulations, drug-likeness studies, ADMET prediction and biological evaluation of novel pyrazole-carboxamides bearing sulfonamide moiety as potent carbonic anhydrase inhibitors. Mol Divers 2024:10.1007/s11030-024-10901-0. [PMID: 38869737 DOI: 10.1007/s11030-024-10901-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2024] [Accepted: 05/17/2024] [Indexed: 06/14/2024]
Abstract
Pyrazoles are unique bioactive molecules with a versatile biological profile and they have gained an important place on pharmaceutical chemistry. Pyrazole compounds containing sulfonamide nuclei also attract attention as carbonic anhydrase (CA) inhibitors. In this study, a library of pyrazole-carboxamides were synthesized and the structures of the synthesized molecules were characterized using FT-IR, 1H-NMR, 13C-NMR and HRMS. Then the inhibition effects of newly synthesized molecules on human erythrocyte hCA I and hCA II isoenzymes were investigated. Ki values of the compounds were in the range of 0.063-3.368 µM for hCA I and 0.007-4.235 µM for hCA II. Molecular docking studies were performed between the most active compounds 6a, 6b and the reference inhibitor, acetazolamide (AAZ) and the hCA I and hCA II receptors to investigate the binding mechanisms between the compounds and the receptors. These compounds showed better interactions than the AAZ. ADMET analyzes were performed for the compounds and it was seen that the compounds did not show AMES toxicity. The stability of the molecular docking results over time was analysed by 50 ns molecular dynamics simulations. Molecular dynamics simulations revealed that 6a and 6b exhibited good stability after docking to the binding sites of hCA I and hCA II receptors, with minor conformational changes and fluctuations.
Collapse
Affiliation(s)
- İrfan Yetek
- Department of Chemistry, Faculty of Arts and Sciences, Dumlupınar University, Kütahya, 43100, Türkiye
| | - Samet Mert
- Department of Chemistry, Faculty of Arts and Sciences, Dumlupınar University, Kütahya, 43100, Türkiye
| | - Ekrem Tunca
- Department of Biochemistry, Faculty of Arts and Sciences, Dumlupınar University, Kütahya, 43100, Türkiye
| | - Alpaslan Bayrakdar
- Vocational School of Higher Education for Healthcare Services, Iğdır University, Iğdır, 76000, Türkiye
| | - Rahmi Kasımoğulları
- Department of Chemistry, Faculty of Arts and Sciences, Dumlupınar University, Kütahya, 43100, Türkiye.
| |
Collapse
|
2
|
Yıldırım A, Atmaca U, Şahin E, Taslimi P, Taskin-Tok T, Çelik M, Gülçin İ. The synthesis, carbonic anhydrase and acetylcholinesterase inhibition effects of sulfonyl chloride moiety containing oxazolidinones using an intramolecular aza-Michael addition. J Biomol Struct Dyn 2023:1-16. [PMID: 38100567 DOI: 10.1080/07391102.2023.2291163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Accepted: 10/26/2023] [Indexed: 12/17/2023]
Abstract
Oxazolidinones are used as various potent antibiotics, in organisms it acts as a protein synthesis inhibitor, focusing on an initial stage that encompasses the tRNA binding process. Novel intramolecular aza-Michael reactions devoid of metal catalysts have been introduced in an oxazolidone synthesis pathway, different from α,β-unsaturated ketones. Oxazolidinone derivatives were tested against acetylcholinesterase (AChE), carbonic anhydrase I and II (hCA I and hCA II) enzymes. All the synthesized compounds had potent inhibition effects with Ki values in the range of 13.57 ± 0.98 - 53.60 ± 6.81 µM against hCA I and 9.96 ± 1.02 - 46.35 ± 3.83 µM against hCA II in comparison to the acetazolamide (AZA) (Ki = 50.46 ± 6.17 µM for hCA I) and for hCA II (Ki = 41.31 ± 5.05 µM). Also, most of the compounds demonstrated potent inhibition ability towards AChE enzyme with Ki values 78.67-231.75 nM and compared to tacrine (TAC) as standard clinical inhibitor (Ki = 142.48 nM). Furthermore, ADMET analysis and molecular docking were calculated using the AChE, hCA I and hCA II enzyme proteins to correlate the data with the experimental data. In this work, recent applications of a stereoselective aza-Michael reaction as an efficient tool for of nitrogen-containing heterocyclic scaffolds and their useful to pharmacology analogs are reviewed and summarized.Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
- Alper Yıldırım
- Department of Chemistry, Faculty of Sciences, Atatürk University, Erzurum, Turkey
| | - Ufuk Atmaca
- Department of Chemistry, Faculty of Sciences, Atatürk University, Erzurum, Turkey
| | - Ertan Şahin
- Department of Chemistry, Faculty of Sciences, Atatürk University, Erzurum, Turkey
| | - Parham Taslimi
- Department of Biotechnology, Faculty of Sciences, Bartin University, Bartin, Turkey
| | - Tugba Taskin-Tok
- Faculty of Arts and Sciences, Department of Chemistry, Gaziantep University, Gaziantep, Turkey
- Department of Bioinformatics and Computational Biology, Institute of Health Sciences, Gaziantep University, Gaziantep, Turkey
| | - Murat Çelik
- Department of Chemistry, Faculty of Sciences, Atatürk University, Erzurum, Turkey
| | - İlhami Gülçin
- Department of Chemistry, Faculty of Sciences, Atatürk University, Erzurum, Turkey
| |
Collapse
|
3
|
Koca M, Gülçin İ, Üç EM, Bilginer S, Aydın AS. Evaluation of antioxidant potentials and acetylcholinesterase inhibitory effects of some new salicylic acid-salicylamide hybrids. JOURNAL OF THE IRANIAN CHEMICAL SOCIETY 2023. [DOI: 10.1007/s13738-023-02775-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/06/2023]
|
4
|
Sivaraman B, Raji V, Velmurugan BA, Natarajan R. Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease. CNS & NEUROLOGICAL DISORDERS DRUG TARGETS 2022; 21:427-449. [PMID: 34602041 DOI: 10.2174/1871527320666210928160159] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/16/2021] [Revised: 08/19/2021] [Accepted: 08/30/2021] [Indexed: 11/22/2022]
Abstract
Acetylcholinesterase (AchE), hydrolase enzyme, regulates the hydrolysis of acetylcholine neurotransmitter in the neurons. AchE is found majorly in the central nervous system at the site of cholinergic neurotransmission. It is involved in the pathophysiology of Alzheimer's diseasecausing dementia, cognitive impairment, behavioral and psychological symptoms. Recent findings involved the inhibition of AchE that could aid in the treatment of Alzheimer's. Many drugs of different classes are being analyzed in the clinical trials and examined for their potency. Drugs that are used in the treatment of Alzheimer's disease are donepezil, galantamine, tacrine, rivastigmine showing major adverse effects. To overcome this, researchers work on novel drugs to elicit inhibition. This review comprises many hybrids and non-hybrid forms of heteroaromatic and nonheteroaromatic compounds that were designed and evaluated for AchE inhibition by Ellman's method of assay. These novel compounds may assist future perspectives in the discovery of novel moieties against Alzheimer's disease by the inhibition of AchE.
Collapse
Affiliation(s)
- Bhuvaneswari Sivaraman
- Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai-97, Tamilnadu, India
| | - Vijaykumar Raji
- Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai-97, Tamilnadu, India
| | - Bala Aakash Velmurugan
- Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai-97, Tamilnadu, India
| | - Ramalakshmi Natarajan
- Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai-97, Tamilnadu, India
| |
Collapse
|
5
|
Mancuso F, De Luca L, Bucolo F, Vrabel M, Angeli A, Capasso C, Supuran CT, Gitto R. 4-Sulfamoylphenylalkylamides as Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae. ChemMedChem 2021; 16:3787-3794. [PMID: 34592052 PMCID: PMC9298201 DOI: 10.1002/cmdc.202100510] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Indexed: 11/21/2022]
Abstract
A current issue of antimicrobial therapy is the resistance to treatment with worldwide consequences. Thus, the identification of innovative targets is an intriguing challenge in the drug and development process aimed at newer antimicrobial agents. The state-of-art of anticholera therapy might comprise the reduction of the expression of cholera toxin, which could be reached through the inhibition of carbonic anhydrases expressed in Vibrio cholerae (VchCAα, VchCAβ, and VchCAγ). Therefore, we focused our interest on the exploitation of sulfonamides as VchCA inhibitors. We planned to design and synthesize new benzenesulfonamides based on our knowledge of the VchCA catalytic site. The synthesized compounds were tested thus collecting useful SAR information. From our investigation, we identified new potent VchCA inhibitors, some of them displayed high affinity toward VchCAγ class, for which few inhibitors are currently reported in literature. The best interesting VchCAγ inhibitor (S)-N-(1-oxo-1-((4-sulfamoylbenzyl)amino)propan-2-yl)furan-2-carboxamide (40) resulted more active and selective inhibitor when compared with acetazolamide (AAZ) as well as previously reported VchCA inhibitors.
Collapse
Affiliation(s)
- Francesca Mancuso
- CHIBIOFARAM DepartmentUniversity of MessinaViale Stagno D'Alcontres98166MessinaItaly
| | - Laura De Luca
- CHIBIOFARAM DepartmentUniversity of MessinaViale Stagno D'Alcontres98166MessinaItaly
| | - Federica Bucolo
- CHIBIOFARAM DepartmentUniversity of MessinaViale Stagno D'Alcontres98166MessinaItaly
| | - Milan Vrabel
- Institute of Organic Chemistry and Biochemistry (IOCB)Czech Academy of SciencesFlemingovo nám. 216000PragueCzech Republic
| | - Andrea Angeli
- NEUROFARBA DepartmentUniversity of FlorenceVia U. Schiff 650019FlorenceItaly
| | - Clemente Capasso
- Institute of Biosciences and BioresourcesCNRVia Castellino 11180131NapoliItaly
| | - Claudiu T. Supuran
- NEUROFARBA DepartmentUniversity of FlorenceVia U. Schiff 650019FlorenceItaly
| | - Rosaria Gitto
- CHIBIOFARAM DepartmentUniversity of MessinaViale Stagno D'Alcontres98166MessinaItaly
| |
Collapse
|
6
|
Yaylı N, Kılıç G, Kahriman N, Kanbolat Ş, Bozdeveci A, Alpay Karaoğlu Ş, Aliyazıcıoğlu R, Erdinç Sellitepe H, Selin Doğan İ, Aydın A, Tatar G. Synthesis, biological evaluation (antioxidant, antimicrobial, enzyme inhibition, and cytotoxic) and molecular docking study of hydroxy methoxy benzoin/benzil analogous. Bioorg Chem 2021; 115:105183. [PMID: 34339978 DOI: 10.1016/j.bioorg.2021.105183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2021] [Revised: 05/31/2021] [Accepted: 07/13/2021] [Indexed: 10/20/2022]
Abstract
In this work, due to the biological activity evaluation, a series of hydroxy methoxy benzoins (1-8), benzils (10-16) and methoxy benzoin/benzil-O-β-d-glucosides (17-28) were synthesized. Antioxidant (FRAP, CUPRAC, DPPH), antimicrobial (16 microorganisms, and two yeast), enzyme inhibition (α-amylase, α-glucosidase, AChE, BChE, and tyrosinase) of all synthesized benzoin/benzil analogs were investigated. Benzoins (1-8) showed the most effective antioxidant properties compared to all three methods. Compound 28 against α-amylase, compound 9 against α-glucosidase, compound 11 against AChE, compound 2 against BChE, and compound 13 against tyrosinase showed the best activities with the better or similar IC50 values as used standards. Hydroxy methoxy benzoin compounds (1-8) among all four groups were seen as the most effective against the tested microorganism. Molecular docking analysis showed that all tested compounds 1-28 (0.01-2.22 µM) had the best binding affinity against AChE enzyme. Cytotoxic effects of the many of compounds (1-16, 21, and 24) also investigated and it was found that they caused different effects in different cells. The LDH tests of compounds 1a + b, 4, 7, 8, 9, 11, 12, 21, and 24, seemed to be effective compared to the positive control cisplatin. The cytotoxicity of compounds 6 (9.24%) for MCF7 cancer cells, 8 (5.16%) and 4 (8.26%) for HT29 cancer cells, 24 (9.84%) for Hep3B cells and 8 (8.52%), 7 (5.70%), 4 (6.94) and 9 (7.22%) for C6 cells were at normal values. And also cytotoxic activity of four compounds (5, 9, 21, and 24) among the all synthetic groups, were evaluated to the HeLa and RPE. Compound 5 showed anticancer activity on HeLa and RPE cancer cells as much as or better than cisplatin which was used as standard.
Collapse
Affiliation(s)
- Nurettin Yaylı
- Department of Pharmacognosy, Faculty of Pharmacy, Karadeniz Technical University, 61080 Trabzon, Turkey.
| | - Gözde Kılıç
- Department of Pharmacognosy, Faculty of Pharmacy, Karadeniz Technical University, 61080 Trabzon, Turkey
| | - Nuran Kahriman
- Department of Chemistry, Faculty of Science, Karadeniz Technical University, 61080 Trabzon, Turkey.
| | - Şeyda Kanbolat
- Department of Biochemistry, Faculty of Pharmacy, Karadeniz Technical University, 61080 Trabzon, Turkey
| | - Arif Bozdeveci
- Department of Biology, Faculty of Arts and Sciences, Recep Tayyip Erdoğan University, 53100 Rize, Turkey
| | - Şengül Alpay Karaoğlu
- Department of Biology, Faculty of Arts and Sciences, Recep Tayyip Erdoğan University, 53100 Rize, Turkey
| | - Rezzan Aliyazıcıoğlu
- Department of Biochemistry, Faculty of Pharmacy, Karadeniz Technical University, 61080 Trabzon, Turkey
| | - Hasan Erdinç Sellitepe
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Karadeniz Technical University, 61080 Trabzon, Turkey
| | - İnci Selin Doğan
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Karadeniz Technical University, 61080 Trabzon, Turkey
| | - Ali Aydın
- Department of Basic Medical Science, Faculty of Medicine, Bozok University, 66900 Yozgat, Turkey
| | - Gizem Tatar
- Department of Biostatistics and Medical Informatics, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Turkey
| |
Collapse
|